Ls Investment Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Ls Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$59.18 - $69.99 $222,516 - $263,162	-3,760 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $9,786 - $13,005	-165 Reduced 4.2%	3,760 $264,000
Q4 2020 Feb 10, 2021	BUY	$50.47 - $66.26 $198,094 - $260,070	3,925 New	3,925 $235,000
Q3 2020 Nov 12, 2020	SELL	$51.97 - $63.0 $74,680 - $90,531	-1,437 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$30.8 - $52.47 $3,603 - $6,138	117 Added 8.86%	1,437 $75,000
Q3 2019 Oct 31, 2019	BUY	$35.66 - $44.99 $47,071 - $59,386	1,320 New	1,320 $50,000

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $804M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.